3-147403964-C-T
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_001168378.1(ZIC4):c.135G>A(p.Lys45Lys) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.21 in 1,536,262 control chromosomes in the GnomAD database, including 35,870 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001168378.1 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZIC4 | NM_032153.6 | c.-15-1152G>A | intron_variant | ENST00000383075.8 | NP_115529.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZIC4 | ENST00000383075.8 | c.-15-1152G>A | intron_variant | 1 | NM_032153.6 | ENSP00000372553.3 |
Frequencies
GnomAD3 genomes AF: 0.179 AC: 27144AN: 152030Hom.: 2650 Cov.: 32
GnomAD3 exomes AF: 0.172 AC: 23758AN: 138504Hom.: 2362 AF XY: 0.174 AC XY: 12918AN XY: 74318
GnomAD4 exome AF: 0.214 AC: 295935AN: 1384114Hom.: 33219 Cov.: 32 AF XY: 0.212 AC XY: 144618AN XY: 683002
GnomAD4 genome AF: 0.178 AC: 27149AN: 152148Hom.: 2651 Cov.: 32 AF XY: 0.175 AC XY: 13026AN XY: 74366
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at